Oxidative stress: The role of cytochromes P450 in oxygen activation

Journal of Chemical Technology and Biotechnology

Volumn 77, Issue 10, 2002, Pages 1095-1100

  Lewis, David F V ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Cytochromes P450; Oxidative stress; Reactive oxygen species

Indexed keywords

ENZYMES; OXYGEN; TUMORS;

OXIDATIVE STRESS;

BIOTECHNOLOGY;

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CATALASE; CYTOCHROME P450; DNA; FLAVINE ADENINE NUCLEOTIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON; LIPID; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXYGEN; PEROXIDE; PEROXY RADICAL; PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RETINOL; SCAVENGER; SINGLET OXYGEN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

BIOTECHNOLOGY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CANCER; CARCINOGENICITY; CATALYSIS; CHEMICAL BOND; CYTOTOXICITY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EMPHYSEMA; ENZYME ACTIVITY; ENZYME DEFECT; HUMAN; IMMUNE RESPONSE; IRON METABOLISM; LIPID PEROXIDATION; MALARIA; METABOLIC ACTIVATION; MULTIPLE SCLEROSIS; MUSCULAR DYSTROPHY; MUTAGENICITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PARKINSON DISEASE; PROTECTION; REVIEW; RHEUMATOID ARTHRITIS; SICKLE CELL ANEMIA;

EID: 0036796112     PISSN: 02682575     EISSN: None     Source Type: Journal    
DOI: 10.1002/jctb.648     Document Type: Review

References (29)

1. Halliwell B, Oxidants and human disease: some new concepts. FASEB Journal 1:358-364 (1987).
2. Halliwell B and Gutteridge JMC, Free Radicals in Biology and Medicine, Clarendon Press, Oxford (1989).
3. Marks DB, Marks AD and Smith CM, Oxygen metabolism and oxygen toxicity, in Basic Medical Biochemistry: A Clinical Approach, Williams and Wilkins, Ch 21 (1996).
4. Halliwell B, Oxygen radicals as key mediators in human disease: fact or fiction?, in Food, Nutrition and Chemical Toxicity, Ed by Parke DV, Ioannides C and Walker R, Smith-Gordon, London. pp 129-138 (1993).
5. Oberley LW and Oberley TD, Reactive oxygen species in the aetiology of cancer, in Drugs, Diet and Disease, Vol 1, Mechanistic Approaches to Cancer Ed by Ioannides C and Lewis DFV, Ellis Horwood, Chichester. pp 47-63 (1993).
6. Parke AL, Lewis DFV and Parke DV, Molecular pathology of drug-disease interactions in chronic autoimmune inflammatory diseases. Inflammopharmacology 1:3-36 (1991).
7. Scott C, Antioxidants: the modern elixir? Chemistry in Britain-November: 879-882 (1995).
8. Foyer CH and Fletcher JM, Plant antioxidants: colour me healthy. Biologists 48:115-120 (2001).
9. Ryan TP and Aust SD, The role of iron in oxygen-mediated toxicities. Critical Reviews in Toxicology 22:119-141 (1992).
10. da Silva JJRF and Williams RJP, The Biological Chemistry of the Elements, Clarendon Press, Oxford (1991).
11. Lewis DFV and Sheridan G, Cytochromes P450, oxygen and evolution. The Scientific World 1:151-167 (2001).
12. Szent-Gyorgi A, Biological oxidation and cancer. International Journal of Quantum Chemistry, Quantum Biology Symposium 9:27-30 (1982).
13. Suzuki YJ and Ford GD, Mathematical model supporting the superoxide theory of oxygen toxicity. Free Radical Biology and Medicine 16:63-72 (1993).
14. Darley-Usmar V, Wiseman H and Halliwell B, Nitric oxide and oxygen radicals: a question of balance. FEBS Letters 369:131-135 (1995).
15. Blake DR, Morris CJ, Dabbagh AJ and Edmonds SE, The persistence of synovial inflammation - a critical role for iron-promoted oxidative injury, in Food, Nutrition and Chemical Toxicity, Ed by Parke DV, Ioannides C and Walker R, Smith-Gordon, London. pp 205-213 (1993).
16. Kappus H, Metabolic reactions: role of cytochrome P450 in the formation of reactive oxygen species, in Cytochrome P450, Ed by Schenkman JB and Griem H, Springer-Verlag, Berlin. pp 145-154 (1993).
17. Lewis DFV, Cytochromes P450: Structure, Function and Mechanism, Taylor & Francis, London (1996).
18. Lewis DEV, Guide to Cytochrome P450 Structure and Function, Taylor & Francis, London (2001).
19. Lewis DFV and Hlavica P, Interactions between redox partners in various cytochrome P450 systems: functional and structural aspects. Biochimica et Biophysica Acta 1460:353-374 (2000).
20. Lewis DFV and Pratt JM, The P450 catalytic cycle and oxygenation mechanism. Drug Metabolism Reviews 30:739-786 (1998).
21. De Groot H and Sies H, Cytochrome P450, reductive metabolism and cell injury. Drug Metabolism Reviews 20:275-284 (1989).
22. Goeptar AR, Scheerens H and Vermeulen NPE, Oxygen and xenobiotic reductase activities of cytochrome P450. Critical Reviews in Toxicology 25:25-65 (1995).
23. Parke DV and Ioannides C, Role of cytochromes P450 in mouse liver tumor production, in Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons, Ed by Stevenson DE, McClain RM, Popp JA, Slaga TG, Ward JM and Pitot HC, Alan R, Liss, Inc, New York. pp 215-230 (1990).
24. Loizou GD and Cocker J, The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone. Human and Experimental Toxicology 20:321-327 (2001).
25. French SW, Biochemistry of alcoholic liver disease. Critical Reviews in Clinical Laboratory Sciences 29:83-115 (1992).
26. Kukielka E and Cederbaum AI, DNA strand cleavage as a sensitive assay for the production of hydroxyl radicals by microsomes: role of cytochrome P4502E1 in the increased activity after ethanol treatment. Biochemical Journal 302:773-779 (1994).
27. Wiseman H and Halliwell B, Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochemical Journal 313:17-29 (1996).
28. Parke DV and Lewis DFV, Safety aspects of food preservatives. Food Additives and Contaminants 9:561-585 (1992).
29. Kayyali R, Pannala AS, Khodr H and Hider RC, Comparative radical Scavenging ability of bidentate iron (III) chelators. Biochemical Pharmacology 55:1327-1332 (1998).